BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21883489)

  • 1. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma and amyloidosis of the tongue.
    Raubenheimer EJ; Dauth J; Pretorius FJ
    J Oral Pathol; 1988 Nov; 17(9-10):554-9. PubMed ID: 3150443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
    van Rijswijk MH; van Heusden CW
    Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of potassium permanganate staining in the classification of systemic amyloidoses].
    Pigrau C; Martínez-Vázquez JM; Ocaña I; Capdevila JA; Ribera E; Muñiz R; Vidal MT
    Med Clin (Barc); 1985 Mar; 84(8):302-4. PubMed ID: 2580195
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
    Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
    Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyloidosis of the A-kappa type].
    Scherwitz C; Linke RP; Schmitt FJ
    Hautarzt; 1986 Jun; 37(6):343-6. PubMed ID: 3087912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
    Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
    Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic amyloidosis: correlations between chemical types of amyloid protein and morphological features.
    Ohyama T; Shimokama T; Yoshikawa Y; Watanabe T
    Mod Pathol; 1990 Jul; 3(4):419-22. PubMed ID: 2217149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of amyloidosis in a Malaysian patient population.
    Looi LM
    Histopathology; 1991 Feb; 18(2):133-41. PubMed ID: 1901294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections.
    Looi LM
    Pathology; 1986 Jan; 18(1):137-40. PubMed ID: 2425332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histopathological and immunohistochemical studies of generalized amyloidosis].
    Li WX
    Zhonghua Bing Li Xue Za Zhi; 1991 Mar; 20(1):35-7. PubMed ID: 2065374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of different amyloids with immunological techniques.
    Chastonay P; Hurlimann J
    Pathol Res Pract; 1986 Dec; 181(6):657-63. PubMed ID: 3104892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies.
    Bindi G; Smith A; Oliveira G; Eccher A; Vatrano S; Alberici F; Cazzaniga G; Galimberti S; Capitoli G; Magni F; Pagni F; L'Imperio V
    J Clin Pathol; 2024 May; 77(6):402-410. PubMed ID: 36813560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
    Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
    Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review.
    Lewis JE; Olsen KD; Kurtin PJ; Kyle RA
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):372-7. PubMed ID: 1565488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic amyloidosis: morphologic differences between systemic AL and AA types.
    Buck FS; Koss MN
    Hum Pathol; 1991 Sep; 22(9):904-7. PubMed ID: 1916751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis.
    Looi LM; Sumithran E
    Hum Pathol; 1988 Jun; 19(6):732-5. PubMed ID: 2454214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic kappa light chain deposition and amyloidosis in multiple myeloma: novel morphological observations.
    Kirkpatrick CJ; Curry A; Galle J; Melzner I
    Histopathology; 1986 Oct; 10(10):1065-76. PubMed ID: 3096869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erosive arthritis in monoclonal gammopathy of uncertain significance: report of four cases.
    Vitali C; Baglioni P; Vivaldi I; Cacialli R; Tavoni A; Bombardieri S
    Arthritis Rheum; 1991 Dec; 34(12):1600-5. PubMed ID: 1747145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.